StockData
PROCTER & GAMBLE Co logo

PROCTER & GAMBLE Co (PG) stock analysis

PGNYSESoap, Detergents, Cleang Preparations, Perfumes, CosmeticsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 12/302% above fair value
$167.67−0.99 (-0.59%)

Close on Nov 11, 2026Market cap $388.62BP/E 25.4Yield 2.54%

StockData Score

Prices as of Nov 11, 2026How the score works

Value3Growth0Performance2Health3Dividend4

Mixed12 of 30 checks passed

Procter & Gamble passes 12 of the 30 checks behind our score; 5 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
3/6
Growth
0/6
Past performance
2/6
Financial health
3/6
Dividend
4/6

What stands out

  • Earnings grew over 5 years

    Net income grew 2.3% a year on average over the last five fiscal years.

  • Interest well covered

    Operating income covers interest expense 22.0 times.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 51.2% of total debt.

  • Low bankruptcy risk

    The Altman Z-score is 5.49; above 3 is the safe zone and below 1.8 the distress zone.

What to watch

  • Margin of safety under 20%

    The price is 1.6% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $167.67 is above our fair value estimate of $165.04.

  • Revenue growing under 10% a year

    Revenue grew 2.0% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew 3.9% a year over the last three fiscal years.

Valuation3/6
  • P/E below its 5-year median

    Procter & Gamble's P/E of 25.4 is below its own 5-year median of 25.7.

  • P/E below the industry

    Procter & Gamble's P/E of 25.4 is below the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median of 29.9.

  • EV/EBITDA below its 5-year median

    Procter & Gamble's EV/EBITDA of 17.9 is below its 5-year median of 19.2.

  • P/S above the industry

    Procter & Gamble's price-to-sales of 4.42 is above the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median of 2.66 (book value is negative, so we use sales).

  • Trading above fair value

    The share price of $167.67 is above our fair value estimate of $165.04.

  • Margin of safety under 20%

    The price is 1.6% above fair value, so there is no margin of safety.

Growth0/6
  • Revenue growing under 10% a year

    Revenue grew 2.0% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew 3.9% a year over the last three fiscal years.

  • Earnings growth not accelerating

    Net income grew -4.4% over the last twelve months, against a 5-year average of 2.3% a year.

  • Growing slower than the industry

    Revenue grew 3.5% over the last twelve months; the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median is 5.9%.

  • Guidance lowered

    Procter & Gamble lowered its fiscal year 2027 repurchase of common shares outlook on Jul 29, 2026.

  • Gross margin slipping

    Gross margin was 49.8% over the last twelve months, against 51.0% a year earlier.

Past performance2/6
  • Return on equity

    Needs positive equity and five years of results.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity against the industry

    Needs positive equity.

  • Earnings grew over 5 years

    Net income grew 2.3% a year on average over the last five fiscal years.

  • Net margin below its 5-year average

    Net margin was 18.2% over the last twelve months, against a 5-year average of 18.3%.

  • Net margin above the industry

    Procter & Gamble's net margin of 18.2% is above the Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median of 0.2%.

Financial health3/6
  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 51.2% of total debt.

  • Interest well covered

    Operating income covers interest expense 22.0 times.

  • Short-term assets don't cover short-term debts

    Current assets are 0.72 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 5.49; above 3 is the safe zone and below 1.8 the distress zone.

Dividend4/6
  • Pays a dividend

    Procter & Gamble paid dividends worth 1.9% of the share price over the last twelve months.

  • Yield below Treasuries

    The 1.9% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Procter & Gamble yields 1.9%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Covered by earnings

    Dividends take 64.2% of net income.

  • Covered by free cash flow

    Dividends take 67.1% of free cash flow.

Scores of similar companies

Our estimate per share

$165.04

The share price is 2% above this estimate.

20%+ below
Near fair value
20%+ above
$167.67Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E27.8×25.7×29.9×$183.5944%
EV/EBITDA18.6×19.2×17.9×$174.2339%
Earnings power7.4% cost of equity––$94.1517%
Fair value$165.04100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 25.7
  • Soap, Detergents, and Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations median 29.9

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$1.60B
Value traded per 1% price move
$1.39B

Downside

Low risk

Typical loss in a bad month
11.2%
Volatility (annualized)
21%
Sharpe ratio, 1 year
0.52
Beta to the S&P 500 (5Y)
0.39

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2012 to 2026

Gross margin

50.2%−1.1 pts over 5 years

Operating margin

22.7%−0.9 pts over 5 years

Net margin

18.4%−0.4 pts over 5 years

See a number that looks wrong?